Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia

Abstract

Our results validate pancreatic cyst fluid PGE₂ as an indicator of IPMN dysplasia, especially in select patients with preoperative pancreatic cyst fluid CEA >192 ng/mL. The inclusion of PGE₂/CEA in a diagnostic biomarker panel can facilitate more optimal treatment stratification of IPMN patients.